Research output per year
Research output per year
Personal profile
Research interests
Regulatory science, rare diseases, orphan drugs
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Access to medicines for rare diseases: A European regulatory roadmap for academia
Rosenberg, N., van den Berg, S., Stolwijk, N. N., Jacobs, B. A. W., Post, H. C., Pasmooij, A. M. G., de Visser, S. J. & Hollak, C. E. M., 2023, In: Frontiers in pharmacology. 14, 1142351.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Bereiding van geneesmiddelen in de apotheek
Translated title of the contribution :Medicine compounding in the pharmacy Research output: Contribution to journal › Article › Professional
-
Development of medicines for rare diseases and inborn errors of metabolism: Toward novel public–private partnerships
Rosenberg, N., Stolwijk, N. N., van den Berg, S., Heus, J. J., van der Wel, V., van Gelder, T., Bosch, A. M., de Visser, S. J. & Hollak, C. E. M., Sept 2023, In: Journal of Inherited Metabolic Disease. 46, 5, p. 806-816 11 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access3 Citations (Scopus) -
Author Reply
van den Berg, S., de Visser, S. J., Timmers, L. & Hollak, C. E. M., 1 Jan 2022, In: Value in Health. 25, 1, p. 158-159 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access -
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review
van der Ree, M. H., van Dussen, L., Rosenberg, N., Stolwijk, N., van den Berg, S., van der Wel, V., Jacobs, B. A. W., Wilde, A. A. M., Hollak, C. E. M. & Postema, P. G., 1 Nov 2022, In: EP Europace. 24, 11, p. 1809-1823 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access8 Citations (Scopus)